
C2i Genomics (סי2אי ג'נומיקס בע"מ)
C2i Genomics (סי2אי ג'נומיקס בע"מ)
Claim
C2i Genomics offers post-surgery monitoring of cancer recurrence and progression by analyzing subtle changes in the pattern of the tumor's DNA. C2i's liquid biopsy is a tool for cancer tumor monitoring. It works by identifying subtle changes in genetic patterns across the entire tumor. Based on bioinformatics and artificial intelligence, it compares thousands of data points obtained from patients' periodic liquid biopsy blood tests to their own baseline of sequenced tumor tissue and whole-genome Show MoreC2i Genomics offers post-surgery monitoring of cancer recurrence and progression by analyzing subtle Show More
Alpha Score
$ 207.00 M
Alpha Score
46.9
Predictions
Overview
Team
Financials
- Partnerships
Relationships
Locations
Competitors
Comparison
News
Product
Regulatory
Clinical
Patent
Publications
Notes
0and0